Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma (Q48264845)

From Wikidata
Jump to navigation Jump to search
scientific article published in February 2007
edit
Language Label Description Also known as
English
Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma
scientific article published in February 2007

    Statements

    Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit